In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of bexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression.
Source: nimh

FDA approval of the postpartum depression treatment brexanolone represents the final phase of a bench-to-bedside journey for this drug — a journey that began in the NIMH Intramural Research Program. NIMH experts are available to provide information on postpartum depression and the importance of, and the science underlying, this new drug.
Source: nimh

On March 14, 2019, Sheena Josselyn, PhD, will present “Making, Breaking, and Linking Memories” as part of the NIMH Director’s Innovation Speaker Series. In her talk, Dr. Josselyn will provide an overview of recent research focusing on how a memory is physically or functionally represented in the brain through a memory trace or “engram.”
Source: nimh

Researchers have identified changes in brain connectivity and brain activity during rest and reward anticipation in children with anhedonia, a condition where people lose interest and pleasure in activities they used to enjoy.
Source: nimh

A research team found nearly one-third of youth ages 10 to 12 years screened positive for suicide risk in emergency department settings, including those seeking help for physical concerns only.
Source: nimh

This comprehensive symposium incorporates multiple viewpoints and experimental procedures to highlight the interaction between attention and awareness, from mind-wandering to mindfulness.
Source: nimh

NIMH Twitter Chat: Eating Disorders
Source: nimh

Husseini K. Manji, MD, FRCPC presents “CNS Drug Discovery: Multiple Challenges, Multiple Opportunities” as part of the NIMH Director’s Innovation Speaker Series.
Source: nimh

Researchers have launched an ultra-large virtual docking library expected to grow to more than 1 billion molecules by next year. It will expand by 1000-fold the number of such “make-on-demand” compounds readily available to scientists for chemical biology and drug discovery.
Source: nimh

Dr. Gordon discusses NIMH’s role in the HEAL (Helping End Addiction Long-term SM) Initiative — the National Institutes of Health(NIH)’s all-in, coordinated response to the opioid epidemic.
Source: nimh